THORACIC CANCER

The following clinical trials related to thoracic cancers are available through the WPAHS. Please click on the link for more detailed information on the trial. Below each trial is the contact information at the WPAHS.

 

Esophageal Cancer

Study Title

A Phase II Study of Neoadjuvant Therapy with Cisplatin, Docetaxel, Panitumumab plus Radiation Therapy followed by Surgery with Locally Advanced Adenocarcinoma of the Distal Esophagus

 

Principal Investigator: Robert Keenan, M.D.

Please also contact study coordinator for more information:

Irina Barskaya, MD, CRA (412-359-6165)

Internal Reference: (RC- 4759/Z4051    Keenan)

_____________________________________________________________

 

Non-Small Cell Lung Cancer

Study Title

S0819, A Randomized Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

 

Principal Investigator: Dulabh Monga, M.D.

Please also contact study coordinator for more information:

Gloria Flannery, RN (Phone 412-359-8379)

Internal Reference: (RC-4993/CTSU  SWOG    Monga)

_____________________________________________________________

Study Title

A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Single-agent Tarceva® (Erlotinib) Following Complete Tumor Resection With or Without Adjuvant Chemotherapy in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma Who Have EGFR-positive Tumors

 

Principal Investigator: Robert Keenan, M.D.

Please also contact study coordinator for more information:

Irina Barskaya, MD, CRA (412-359-6165)

Internal Reference: (RC-4350/OSI-774-302  Keenan)

_____________________________________________________________

Study Title

A Randomized Phase III Trial of Adjuvant Therapy in Early Stage Non-small Cell Lung Cancer Evaluating the Potential Utility of a Genomic Prognostic Model to Identify Patients as Candidates for Adjuvant Chemotherapy

 

Principal Investigator: Robert Keenan, M.D.

Please also contact study coordinator for more information:

Irina Barskaya, MD, CRA (412-359-6165)

Internal Reference: (RC-4793 /CALGB 30506   Keenan)

_____________________________________________________________

Study Title

A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (≤ 2 CM) Peripheral Non-Small Cell Lung Cancer

 

Principal Investigator: Robert Keenan, M.D.

Please also contact study coordinator for more information:

Irina Barskaya, MD, CRA (412-359-6165)

Internal Reference: (RC-4394/CALGB 140503   Keenan)

_____________________________________________________________

Study Title

The Cancer and Leukemia Group B (CALGB) Lung Cancer Tissue Bank

 

Principal Investigator: Robert Keenan, M.D.

Please also contact study coordinator for more information:

Irina Barskaya, MD,CRA (412-359-6165)

Internal Reference: (RC- 4407/CALGB 140202   Keenan)

 

Study Title

A Randomized Double-blind Multicenter Phase III Trial of BIBF 1120 Plus Pemetrexed vs. Pemetrexed/ Placebo in Advanced or Recurrent Non Small Cell Lung Cancer Patients After Failure of First Line Therapy

 

Principal Investigator: Mohammed Islam, M.D.

Please also contact study coordinator for more information:

Rich Wonder, RN, CCRC (Phone 412-204-8125)

Internal Reference: ( WPCI 2009-11/Boehinger-Ingelheim Islam)

 

 



West Penn Allegheny Cancer Institute Home
Cancer Care
Our SpecialistsClinical Trials
Cancer InfoAbout UsContact Us
Visit the West Penn Allegheny Health System

© West Penn Allegheny Health System

Privacy Statement | Legal Disclaimer

This website is for informational purposes only and not intended as medical advice or a substitute for a consultation with a professional healthcare provider.